Refine
Has Fulltext
- yes (41)
Is part of the Bibliography
- yes (41)
Year of publication
- 2003 (41) (remove)
Document Type
- Doctoral Thesis (40)
- Journal article (1)
Language
- English (41) (remove)
Keywords
- Maus (3)
- Namibia (3)
- Namibia <Nordwest> (3)
- Analoga (2)
- Genmutation (2)
- Geomorphologie (2)
- Molekulargenetik (2)
- Netzhaut (2)
- RPE (2)
- Rezeptor (2)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (12)
- Institut für Humangenetik (4)
- Institut für Geologie (3)
- Julius-von-Sachs-Institut für Biowissenschaften (3)
- Institut für Mineralogie und Kristallstrukturlehre (2)
- Institut für Organische Chemie (2)
- Institut für Pharmazie und Lebensmittelchemie (2)
- Institut für Physikalische und Theoretische Chemie (2)
- Medizinische Klinik und Poliklinik I (2)
- Volkswirtschaftliches Institut (2)
A theory of managed floating
(2003)
After the experience with the currency crises of the 1990s, a broad consensus has emerged among economists that such shocks can only be avoided if countries that decided to maintain unrestricted capital mobility adopt either independently floating exchange rates or very hard pegs (currency boards, dollarisation). As a consequence of this view which has been enshrined in the so-called impossible trinity all intermediate currency regimes are regarded as inherently unstable. As far as the economic theory is concerned, this view has the attractive feature that it not only fits with the logic of traditional open economy macro models, but also that for both corner solutions (independently floating exchange rates with a domestically oriented interest rate policy; hard pegs with a completely exchange rate oriented monetary policy) solid theoretical frameworks have been developed. Above all the IMF statistics seem to confirm that intermediate regimes are indeed less and less fashionable by both industrial countries and emerging market economies. However, in the last few years an anomaly has been detected which seriously challenges this paradigm on exchange rate regimes. In their influential cross-country study, Calvo and Reinhart (2000) have shown that many of those countries which had declared themselves as ‘independent floaters’ in the IMF statistics were charaterised by a pronounced ‘fear of floating’ and were actually heavily reacting to exchange rate movements, either in the form of an interest rate response, or by intervening in foreign exchange markets. The present analysis can be understood as an approach to develop a theoretical framework for this managed floating behaviour that – even though it is widely used in practice – has not attracted very much attention in monetary economics. In particular we would like to fill the gap that has recently been criticised by one of the few ‘middle-ground’ economists, John Williamson, who argued that “managed floating is not a regime with well-defined rules” (Williamson, 2000, p. 47). Our approach is based on a standard open economy macro model typically employed for the analysis of monetary policy strategies. The consequences of independently floating and market determined exchange rates are evaluated in terms of a social welfare function, or, to be more precise, in terms of an intertemporal loss function containing a central bank’s final targets output and inflation. We explicitly model the source of the observable fear of floating by questioning the basic assumption underlying most open economy macro models that the foreign exchange market is an efficient asset market with rational agents. We will show that both policy reactions to the fear of floating (an interest rate response to exchange rate movements which we call indirect managed floating, and sterilised interventions in the foreign exchange markets which we call direct managed floating) can be rationalised if we allow for deviations from the assumption of perfectly functioning foreign exchange markets and if we assume a central bank that takes these deviations into account and behaves so as to reach its final targets. In such a scenario with a high degree of uncertainty about the true model determining the exchange rate, the rationale for indirect managed floating is the monetary policy maker’s quest for a robust interest rate policy rule that performs comparatively well across a range of alternative exchange rate models. We will show, however, that the strategy of indirect managed floating still bears the risk that the central bank’s final targets might be negatively affected by the unpredictability of the true exchange rate behaviour. This is where the second policy measure comes into play. The use of sterilised foreign exchange market interventions to counter movements of market determined exchange rates can be rationalised by a central bank’s effort to lower the risk of missing its final targets if it only has a single instrument at its disposal. We provide a theoretical model-based foundation of a strategy of direct managed floating in which the central bank targets, in addition to a short-term interest rate, the nominal exchange rate. In particular, we develop a rule for the instrument of intervening in the foreign exchange market that is based on the failure of foreign exchange market to guarantee a reliable relationship between the exchange rate and other fundamental variables.
Summary Myelin protein zero (P0) is a key myelin component in maintaining the integrity and functionality of the peripheral nervous system. Mutated variants are the cause for several disabilitating peripheral neuropathies such as Charcot-Marie-Tooth disease or Dejerine –Sotas syndrome. Using P0 knockout mice - a mouse model for these diseases - together with their wt counterparts on C57BL/6 background we studied the shaping of the T-cell repertoire specific for P0 in the presence and in the absence of this protein during the ontogeny of T-cells. Our approach was to use a series of overlapping 20-mer peptides covering the entire amino acid sequence of P0. This series of P0 peptides was employed for epitope mapping of the H2-Ab restricted T cell response. Thus, P0 peptide 5 (P0 41-60) in the extracellular domain of P0 was identified as the main immunogenic peptide. The immunogenic peptide containing the core immunodominant determinant in the P0 sequence was employed in studies of tolerance, revealing a highly reactive P0 specific T-cell repertoire in P0 ko mice while in wt mice the high avidity repertoire was inactivated in order to ensure self tolerance. In wild type and heterozygous P0 mice tolerance is not dependent on gene dosage. P0 is a tissue specific antigen whose expression is limited to myelinating Schwann cells. The classical view on tolerance to tissue specific antigens attributed this role to peripheral mechanisms. Driven by the finding that intrathymic expression of tissue-specific antigens is a common occurrence, we confirmed that “promiscuous” expression on thymic stroma holds true also for myelin P0. In addition, using bone marrow chimeras we investigated the capacity of bone marrow derived cells versus nonhematopoietic cells to induce tolerance towards P0. Our findings show that bone marrow derived cells although tolerogenic to some degree are not sufficient to mediate complete tolerance. P0 expression on cells with origin other than bone marrow showed to be sufficient and necessary to induce sound tolerance. We identified one cryptic (P0 peptide 8) and two subdominant epitopes (P0 petides 1, and 3). P0 peptide 8 was reactive in both wt and P0 ko mice. Peptides 1 and 3 were immunogenic in P0 ko but not in wt mice. Several P0 peptides including the immunogenic peptide 5 were involved in direct and adoptive transfer EAN studies. None of them induced clinical signs of EAN. Immunization with P0 peptide 3 did induce inflammation of the peripheral nerves reflected by the infiltration of macrophages and CD3 positive cells. More studies involving highly P0 specific T-cell lines are needed to characterize the P0 induced EAN. Our findings may have direct implications for secondary autoimmunity and inflammation in peripheral nerves developing after correcting the P0 genetic defect by gene therapy in aforementioned diseases.
Two isoforms of human CD23 (CD23a and CD23b) have been described. They differ by only 6-7 residues in the N-terminal cytoplasmic tail. CD23a is restrictively expressed on B-cells while CD23b is inducible on B-cells, as well as monocytes, eosinophils, macrophages and a variety of other cell types, after IL-4 stimulation. The two isoforms seems to have different functions. CD23a appears to be the isoform associated with endocytosis of IgE immune complexes and mediating antigen presentation on B-cells. CD23b has a phagocytosis motif and seems to be involved in the phagocytosis of IgE-coated particles, cytokine release and the generation of superoxides. Previous studies indicate that the two isoforms connect to different signal transduction pathways. Comparing the cells that express only one or both CD23 isoforms suggests that CD23b is involved in upregulating cAMP and iNOS, whereas CD23a mediates an increase in intracellular calcium. In the main part of the study we investigated how the CD23a B-cell specific expression is regulated. Pax-5 is a B-cell restricted transcription factor with an essential role in early and late B-cell development. Putative Pax-5 binding sites have been predicted in the CD23a proximal promoter. Analyses of the CD23a promoter revealed three putative Pax-5 binding sites with more than 50% homology to the consensus sequence. One of these sites, named CD23-1 can compete a high affinity Pax-5 binding site or can directly bind Pax-5 protein in electrophoretic mobility shift assays. Introducing mutations into this site abrogates the binding. A different approach, in which overlapping peptides covering the length of the CD23a promoter were tested in competition assays against a high affinity binding site, also revealed CD23-1 as the only site that directly binds Pax-5 protein. Expression of Pax-5 in 293 cells resulted in a 7-fold activation of a CD23a core promoter construct. Co-transfection together with STAT6 showed that Pax-5 cooperates with this transcription factor in enhancing the level of transcription of a CD23a extended promoter construct. Most importantly, ectopic expression of Pax-5 in the monocytic cell line U-937 that regularly expresses only the CD23b isoform enabled a significant CD23a expression after stimulation with IL-4 and PMA. Our results suggest that Pax-5 is a key regulator of the B-cell restricted expression of the CD23a isoform. In the second part of the project, we used a yeast two-hybrid system (CytoTrapTM from Stratagene) in order to look for cytoplasmic interaction partners for the CD23 receptor. The system was established in order to reach a high efficiency of transformation and different bait vector constructs were made. The screening was performed using a human spleen library cloned in the target vector of the system. The first bait constructs used (pSosCD23a and pSosCD23b) expressed the very short (22 amino acids) cytoplasmic tails of the isoforms at the C-terminal end of the fusion protein (human SOS). Improved bait constructs, (pSosCD23a+Linker and pSos CD23b+Linker) expressed the cytoplasmic tail of CD23a/b at the N-terminal side of the human SOS and had in consequence the N-terminal part free as a bait, as it occurs in vivo. A flexible linker region separated the fusion proteins in order to make the small amino acid bait chain more obvious. Approximately three million library clones were screened with these various constructs. No “true positive” interaction was detected. A relatively high number of “false positive” clones were obtained and checked in another two-hybrid system. A new bait construct, in which the tyrosine residue in the cytoplasmic tail of CD23a was replaced by a glutamic acid residue will be used for future screening. The system was also used in order to test the interaction between CD23 and p59fyn, a member of the Src family of protein kinases that was mentioned to associate with CD23a. No interaction was detected by using the CytoTrap two-hybrid system. In conclusion, the key result of the study demonstrates that Pax-5 is a main regulator of the B-cell specific expression of the CD23a isoform. In addition, a two-hybrid system was established and employed in order to look for cytoplasmic interaction partners for CD23.
Cellular proliferation, differentiation and survival in response to extracellular signals are controlled by the signal transduction pathway of Ras, Raf and MAP kinase. The Raf proteins are serine/threonine kinases with essential function in growth/differentiation/survival - related signal transduction events. In mammals, three functional (A-, B-, and C-Raf) genes were described. Biochemical studies suggest overlapping and differential utilization of Raf isozymes. However, the frequent co-expression of Raf isozymes and their multiple activators and effectors impedes the full understanding of their specific roles. The elucidation of these roles is important due to the involvement of the Ras/Raf/MEK/MAP kinase cascade in human disorders especially in tumor development and progression. B-Raf was shown to posses the strongest kinase activity among Raf kinases and display antiapoptotic properties. Mice deficient in B-Raf show overall growth retardation and die between E10.5 and E12.5 of vascular defects caused by excessive death of differentiated endothelial cells. To elucidate the redundancy of Raf isozymes during embryonic development and to rescue B-Raf-/- (KO) phenotype, B-Raf alleles were disrupted by introducing A-Raf cDNA under the control of endogenous B-Raf promoter. The resulting BRaf A-Raf/A-Raf (KIN) phenotype depends on genetic background. The living embryos displaying normal development but size reduction were found with low incidence at E12.5d-16.5d. All of them displayed the rescue of vascular system. One adult p20 mouse without any visible defects in development and behavior was obtained. On the other hand, the processes of neurogenesis and neural precursors migration in survived embryos were disturbed which led in some cases to underdevelopment of different brain compartments. TUNEL and cell proliferation (PCNA staining) assays revealed more apoptotic (E13.5d) and less proliferating(E12.5d cells within ventricular and sub-ventricular zones of brain ventricles and in striatum of KIN embryos. In addition, more apoptotic cells were detected in many other tissues of E13.5d and in lung of E16.5d KIN embryos but not in adult KIN mouse. p20 KIN mouse demonstrated reduced fraction of neural precursor cells in sub-granular zone of hippocampus and mature neurons in olfactory bulb. The other processes of neurogenesis were not disturbed in adult KIN animal. Fibroblasts obtained from KIN embryos demonstrated less proliferative ability and were more susceptible to apoptotic stimuli compared to WT. This was accompanied by the reduction of active ERK and Akt required for survival, and with decrease of inactive phosphorylated BAD. The kinetic of both ERK and Akt phosphorylation upon serum stimulation was delayed. All these data indicate that moderate A-Raf kinase activity can prevent the endothelial apoptosis but is not enough to completely rescue the other developmental consequences.
Summary Background: In a previous study, nitrate reductase (NR, EC 1.6.6.1) from leaves of Ricinus communis L. showed different regulatory properties from most other higher plants NR's by an unusually strong Mg2+-sensitivity, a different pH-activity profile and only little ATP-dependent inactivation. The aim of this work was to elucidate the deviating properties of Ricinus NR in more details, from both molecular and physiological aspects. For that purpose, the NR gene from R. communis was cloned, expressed heterologously and characterized. Results: The deduced protein sequence showed that Ricinus NR shared high similarity with other NRs, apart from the N-terminal region. In the N-terminal region, the Ricinus NR possesses an acidic stretch which is conserved only in higher plants. Within the Moco-binding domain the Ricinus NR contained few amino acid residues which were unique in comparison with 17 plant NRs, including His103, Gln123, Val266 and Ala284 where other NRs possess asparagine, arginine, aspartate and praline. In the Dimer interface and Hinge 1 regions, the Ricinus NR also had some unique residues like Asn460 and Ala498 where other NRs have isoleucine and glycine instead. The Ricinus NR possesses an Arg482 which provides an additional predicted Trypsin cleavage site within 481KRHK484 (while most of plant-NRs possess KPHK). Additionally, the Ricinus NR contains a serine phosphorylation site (Ser-526) within the potential 14-3-3 binding motif 523KSVS*TP528, which is a common characteristic of nitrate reductases. In the C-Terminus of Ricinus NR a sequence 886CGPPP890 confirmed that Ricinus NR is a NADH-specific enzyme. Functional Ricinus NR protein was expressed in Pichia pastoris and compared with the features of Arabidopsis NR2 synthesized by the same expression system (AtNR2). The recombinant Ricinus NR (RcNR) itself was unresponsive to the incubation with MgATP, and so was AtNR2. As yeast extracts might lack factors required for NR regulation, desalted leaf extracts containing NR kinases and 14-3-3s were prepared from 4-day darkened (and therefore NR-free) leaves of Arabidopsis (ADL), spinach (SDL) and Ricinus (RDL), and added to the assay of RcNR and AtNR2 to check for ATP-dependent inactivation and Mg2+-sensitivity. When RcNR was combined with the NR-free extracts described above, it's unusually high Mg2+-sensitivity was restored only by incubation with RDL, but it remained unresponsive to ATP. In contrast, AtNR2 became inactive when incubated with the protein mixtures and ATP. It is obvious that one or some factors existing in RDL could interact with RcNR and therefore provide its high Mg2+-sensitivity. Interestingly, incubation of AtNR2 with different NR-free leaf extracts gave a significant activation of the enzyme activities, both in Mg2+ and EDTA, which were not observed in the case of RcNR. Moreover, using ammonium sulfate to fractionation the RDL revealed that about 0.2 mg of the protein factor(s) from 0-35% of ammonium sulfate precipitation was sufficient to provide the maximum inhibition of the RcNR. Conclusions: The insensitivity to ATP appears an inherent property of Ricinus NR, whereas the high Mg2+-sensitivity depends on one or several factors in Ricinus leaves. This as yet unknown factor(s) was boiling-sensitive and could be precipitated by ammonium sulfate. It appeared to interact specifically with recombinant Ricinus-NR to provide the Mg2+-sensitivity of the authentic leaf enzyme. Presumably, there is also a positive regulatory factor(s) for nitrate reductase existing in the leaves of higher plants.
Transplantation is now firmly established as a therapeutic approach to extend and improve the life of patients in the final stages of organ failure. It has been demonstrated that transplantation between genetically non-identical individuals leads to the activation of the recipient’s alloimmune response as a major determinant of transplant outcome. T cell recognition of foreign MHC molecules plays a key role in initiating and sustaining allograft rejection. To prevent the risk of rejection, patients are given immunosuppressive drugs, which are non-specific and have major side-effects (infections, malignancies). It has been shown that the alloreactive T cells specifically recognize donor MHC-derived peptides. This implies that it may be possible to develop antigen-specific strategies in order to modulate the alloimmune response by peptide analogues and specifically altered peptide ligands. The purpose of this study was to explore the potential of “recipient-adapted” analogues from the dominant MHC class I peptide to modulate the alloimmune response. Beside the significant role of donor dominant determinants in the rejection process, we tested seven 13-to-24-mer peptides from the Wistar-Furth MHC class I molecule (WF, RT1.Au) for their possible immunogenicity in a fully MHC-mismatched WF to Lewis (LEW, RT1l) rat strain combination. Secondly, the immunodominant allopeptide was selected to generate analogues in order to investigate their modulatory capacity. All peptides were tested in vitro in a standard proliferation assay and in vivo using a heterotopic heart transplantation model. Our findings show that five peptides (P1-P5) were able to induce specific T cell proliferation in LEW responders. Furthermore, we found a hierarchical distribution of the determinants: peptide P1 as a good candidate for the immunodominant determinant, while P2, P3, P4, and P5 as subdominant epitopes and the other two peptides, P6 and P7, as non-immunogenic determinants of WF MHC class I molecule. Furthermore, the dominance of P1 was confirmed by the strong proliferation induced after immunization with a mixture of peptides in the presence of P1. This hierarchical distribution of the proliferative response correlated with the cytokine production. Peptide P1, comprising only 3 allogeneic amino acids (L5, L9, and T10) induced the strongest T cell proliferation and produced high levels of cytokines, especially IL-2 and IFN-g. In addition, the immunodominance of peptide P1 was confirmed by the significant reduction in the allograft survival time in comparison to the non-immunized control animals. Since the TCR Vß repertoire of rejected graft-infiltrating cells in rejected allografts was similar to the profile observed after in vitro restimulation of P1-primed T cells, we concluded that peptide P1 is able to activate the alloreactive T cell population. Our results demonstrate the particular role of the dominant peptide P1 (residues 1-19) in the allograft rejection in WF to LEW rat strain combination. In the second set of experiments, we investigated the fine specificity of the dominant peptide P1-activated T cells using peptide analogues from P1. The “recipient-adapted” analogues were designed by changing the allogeneic RT1.Au amino acids (L5, L9, T10) one-by-one with the correspondent syngeneic RT1.Al amino acids (M5, D9, I10) in the sequence of peptide P1. The six peptide analogues (A1.1-A1.6) consisting of either one or two allogeneic amino acids were able to induce a specific T cell proliferative response and cytokine production. Analogue A1.5 with only one allogeneic amino acid (L5) was of particular interest because it induced a low T cell proliferation and high cytokine levels, especially IL-4 and IL-10. In addition, immunization with A1.5 did not influence the allograft survival time in comparison to the non-immunized LEW recipients. A1.5 was the only analogue able to down-regulate the proliferation of P1-primed T cells. Our results reveal that A1.5 is an MHC competitor as confirmed by the in vitro MHC competition assay and the inhibition of the negative effect of P1 on the allograft survival time when recipients were immunized with a mixture of P1 and A1.5. These findings suggest that it is possible to design peptide analogues, such as A1.5, which do not stimulate the dominant peptide P1-specific T cell population and even more, are able to block its presentation in the MHC molecule. In all, the results indicate that the specific suppression of indirect allorecognition can be achieved by using peptide analogues of the dominant allopeptide.
This work is investigating the electronic structure of organic thin films. A central question in this respect is the influence of the interaction between the molecules in the condensed phase and the interaction at metal-organic interfaces on the electronic properties. For this purpose the experimental methods Photoelectron Spectroscopy (PES) and Near Edge X-ray Absorption Finestructure Spectroscopy (NEXAFS) were applied with highest energy resolution. In addition, ab initio calculations were performed for the theoretical simulation of NEXFAS spectra. The investigation is mainly focussing on thin, vacuum sublimated films of aromatic model molecules with oxygen-containing functional groups (NTCDA, PTCDA, NDCA, BPDCA and ANQ) and Ag(111) surfaces. Due to their large, delocalised p-systems these molecules have very interesting properties for their application in electronic devices. Due to the high energy resolution of third generation synchrotron sources the vibronic fine structure in the NEXAFS spectra of these large molecules could be resolved for the first time in the condensed phase. A comparison of the data of the different molecules provides interesting insight into the coupling between electronic transition and vibronic excitation. Although for these molecules a variety of different vibronic modes exist, the NEXAFS data show that preferentially only on mode couples to each electronic transition. The high-resolution PES spectra of the molecules NTCDA, PTCDA, NDCA, BPDCA and ANQ show distinct differences thus providing a fingerprint for each investigated substance. A comparative analysis of the spectra enabled us to define the 1s binding energies of all chemically different carbon and oxygen atoms. Additional structures in the spectra can be assigned as shake-up satellites. The five molecules are an ideal model system for the investigation of fundamental aspects of core electron spectroscopy, such as initial and final state effects and satellites, that are influenced by the intra- and intermolecular electron distribution in the ground and core ionized state. An important aspect in this thesis is the spectroscopic investigation of structurally different NTCDA monolayer phases on the Ag(111) surface. Marked differences in the electronic structures of the different phases, that can be assigned to differences in the metal-adsorbate interaction, could be demonstrated by XPS and NEXAFS. The substrate bonding can be characterized as chemisorptive for both, the compressed as well as the relaxed NTCDA monolayer, which can be unambiguously deduced from the analysis of satellite structures in the O 1s and C 1s XPS spectra. These satellites are due to dynamic screening by charge transfer from the substrate. The NEXAFS data show consistently, that the NTCDA LUMO becomes partly occupied upon adsorption. Highly interesting phase transitions into disordered low-temperature phases occur upon cooling to 160 K for both, the compressed and the relaxed NTCDA monolayer. Thereby, the adsorbate-substrate bonding is increased and the NTCDA LUMO becomes completely occupied. This can be observed in the NEXAFS data, where transitions involving LUMO final states are quenched. Simultaneously, the XPS data show a distinctly decreased intensity of unscreened photoemission states due to enhanced charge transfer screening. In addition, a hysteresis behaviour could be demonstrated for the phase transition of the relaxed monolayer by temperature dependent NEXAFS experiments and the hysteresis curve was determined. The hysteresis could be quantified to approx. 20 K. From SPA-LEED experiments the activating energy for the phase transition of the relaxed monolayer upon cooling could be determined to 60 meV. Finally, a NEXAFS investigation of polyethylene samples with different comonomer content is presented. Differences in the absorption spectra between samples with different comonomer content could be unambiguously assigned to the different crystallinities of the samples by heating a highly crystalline sample in situ close to the melting temperature. Ab initio calculations on a model matrix of butane molecules show, that the spectra of crystalline and amorphous polyethylene differ distinctly due to the intermolecular interaction, which can be observed best for resonances with strong Rydberg character. Thus, the differences in the PE spectra can be explained by the superposition of the signatures of crystalline and amorphous moieties, that are mixed according to the respective crystallinity.
Zars and co-workers were able to localize an engram of aversive olfactory memory to the mushroom bodies of Drosophila (Zars et al., 2000). In this thesis, I followed up on this finding in two ways. Inspired by Zars et al. (2000), I first focused on the whether it would also be possible to localize memory extinction.While memory extinction is well established behaviorally, little is known about the underlying circuitry and molecular mechanisms. In extension to the findings by Zars et al (2000), I show that aversive olfactory memories remain localized to a subset of mushroom body Kenyon cells for up to 3 hours. Extinction localizes to the same set of Kenyon cells. This common localization suggests a model in which unreinforced presentations of a previously learned odorant intracellularly antagonizes the signaling cascades underlying memory formation. The second part also targets memory localization, but addresses appetitive memory. I show that memories for the same olfactory cue can be established through either sugar or electric shock reinforcement. Importantly, these memories localize to the same set of neurons within the mushroom body. Thus, the question becomes apparent how the same signal can be associated with different events. It is shown that two different monoamines are specificaly necessary for formation of either of these memories, dopamine in case of electric shock and octopamine in case of sugar memory, respectively. Taking the representation of the olfactory cue within the mushroom bodies into account, the data suggest that the two memory traces are located in the same Kenyon cells, but in separate subcellular domains, one modulated by dopamine, the other by octopamine. Taken together, this study takes two further steps in the search for the engram. (1) The result that in Drosophila olfactory learning several memories are organized within the same set of Kenyon cells is in contrast to the pessimism expressed by Lashley that is might not be possible to localize an engram. (2) Beyond localization, a possibible mechanism how several engrams about the same stimulus can be localized within the same neurons might be suggested by the models of subcellular organisation, as postulated in case of appetitive and aversive memory on the one hand and acquisition and extinction of aversive memory on the other hand.
The human retina is a multilayered neuroectodermal tissue specialized in the transformation of light energy into electric impulses which can be transmitted to the brain where they are perceived as vision. Since the retina is easily accessible and functional aspects are directly recordable, the study of this tissue has been at the forefront of neuroscience research for over a century. Studies have revealed that the distinct functions of the retina require a large degree of differentiation which is achieved by the coordinated function of approximately 55 different cell types. The highly structured anatomy and the functional differentiation of the retina is a result of its distinctive transcriptome and proteome. Due to the complexity of the retina it has been difficult to estimate the number of genes actively transcribed in this tissue. Great efforts in the elucidation of retinal disease genes have led to the identification of 139 retina disease loci with 90 of the corresponding genes cloned thus far . In contrast to the success in the hereditary disorders, efforts to identify the genetic factors conferring manifestations known as age-related macular degeneration (AMD) have revealed sparse results. AMD is a retinal disease affecting a significant percentage of the older population. This disorder is likely due to exogenic as well as genetic factors. To further our understanding of retinal physiology and facilitate the identification of genes underlying retinal degenerations, particularly AMD, our efforts concentrated on the systematic analysis of the retinal transcriptome. Since approximately half of all retinal degeneration-associated genes identified to date are preferentially expressed in retina, it is plausible that the investigation of gene expression profiles and the identification of retina-expressed transcripts could be an important starting point for characterizing candidate genes for the retinal diseases. The expressed sequence tags approach included the assessment of all retinal expressed sequence tags (EST) clusters indexed in the UniGene database and of 1080 single-pass ESTs derived from an in-house generated human retina suppression subtracted hybridization (SSH) cDNA library. In total, 6603 EST clusters were evaluated during this thesis and detailed in-silico analysis was performed on 750 EST clusters. The expression of the genes was evaluated using reverse transcriptase-polymerase chain reaction (RT-PCR), followed by confirmation using quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR), as well as conventional and virtual Northern blot analysis. The expression profiling of 337 selected EST clusters led to the identification of 111 transcripts, of which 60 are specific or abundant to the retina, 3 are expressed at high levels in the retinal pigment epithelium (RPE), and 48 are expressed in brain as well as in retina. The EST approach used to select candidate transcripts allowed us to assess the effectiveness of the two available resources, the UniGene database and the retinal SSH (retSSH) cDNA library. From the results obtained, it is evident that the generation of suppression subtracted libraries to identify cell-specific transcripts constitutes the most straight-forward and efficient strategy. In addition to the high percentage of candidate genes that are identified from an SSH cDNA library, it has the added benefit that genes expressed at low levels can be identified. Furthermore, comparison of our retina-enriched gene set with previously published studies demonstrated only limited overlap of the identified genes further confirming the valuable source of retinal genes from our retinal SSH cDNA library. The effort of our and other groups has resulted in the establishment of the full-length coding sequence of 55 of the 111 genes uniquely or preferentially expressed in the retina. Using various methods such as bioinformatical analysis, EST assembly, cDNA library screening, and rapid amplification of cDNA ends (RACE) a number of genes were cloned in the scope of this thesis including C1orf32, C4orf11, C7orf9, C12orf7, C14orf29, DAPL1, and GRM7. Bioinformatic analyses and cDNA library screening were used to isolate the full-length cDNA sequence and determine the genomic organization of C7orf9, also identified as RFRP. This 1190 bp retina-specific transcript from chromosome 7p15.3 encodes a precursor protein for at least two small neuropeptides, referred to as RFRP-1 and RFRP-3. Since C7orf9 is localized in the critical region for dominant cystoid macular dystrophy (CYMD) its role in the pathology was investigated. Southern blot analysis and sequencing of samples from two affected individuals of the original pedigree used to localize the disease gene excluded the gene from involvement in this disease. Multiple isoforms of the C12orf7 gene were assembled from a number of clones identified from library screenings, PCR amplifications, and RACE experiments. The gene variants, transcribed from chromosome 12q13.13, have been found to be expressed exclusively in retina. Because of the multiple alternative splicing of the gene, we can only speculate about the nature of the protein it encodes. The longest transcript, which includes all six exons plus the last intervening sequence, encodes a 471 aa protein which contains a nuclear localization signal and five ankyrin repeats. The existence of many isoforms is also observed in mouse suggesting that they may have a relevant role in cellular physiology. Five novel splice variants of the glutamate metabotropic receptor 7 (GRM7) resulting from the use of alternative 3’-end exons were identified and characterized. One of the novel variants, GRM7_v3, encodes a 924 aa protein and is therefore the longest putative GRM7 protein reported to date. Even though they are not retina-specific, the isoforms are preferentially expressed in the nervous system. Although the functional properties of the specific carboxyl-termini are still unclear, it is known that axon targeting of GRM7_v1 is mediated by the last 60 aa of the protein. Hence the novel isoforms may direct the protein to specific subcellular localizations. The C1orf32 gene, preferentially expressed in retina, is organized in 10 exons and is transcribed from chromosome 1q24.1. Bioinformatic analyses of the 639 aa putative protein not only identified the mouse and rat orthologous genes but also the LISCH7 gene as a potential member of the same family. Since the LISCH7 protein has been shown to function as a low density lipoprotein receptor, the C1orf32 protein may be involved in retinal lipid homeostasis. Disturbances in lipid metabolism have been proposed as one of the pathways involved in AMD etiology. Thus, the role of C1orf32 in this complex disease should be investigated. Expression analyses of the death-associated protein-like 1 (DAPL1) gene revealed that it is expressed in both the retina and the RPE at high levels. The 552 bp transcript encodes a 107 aa putative protein and is transcribed from chromosome 2q24.1. In-silico analyses identified an additional 12 related proteins from various species which share high similarity constituting a novel protein family. The similarity to the death-associated-protein (DAP) is particularly interesting since this protein has been found to be indispensable for programmed cell death. Therefore, DAPL1 is an excellent candidate for retinal disease as apoptosis is generally the ultimate cause in retinal degeneration. The retina-specific C4orf11 and C14orf29 genes localized on chromosome 4q21.22 and 14q22.1, respectively, are both transcribed in more than one isoform. The encoded proteins do not contain any known domains but because of their retina-specific expression they may be important for proper retinal physiology. As part of the long-term goals of the project, several of the cloned genes are being genotyped to construct single nucleotide polymorphism (SNP) maps. Projects to investigate haplotype frequencies of candidate genes in large cohorts of controls and AMD patients are ongoing. Thus, by establishing a collection of 111 genes expressed exclusively or preferentially in the retina, the present work has laid the foundation for future research in retinal diseases.
In vitro and in vivo studies on the activating platelet collagen receptor glycoprotein VI in mice
(2003)
The work summarized here focused on the characterization of the murine platelet collagen receptor glycoprotein (GP) VI and was performed to evaluate its potential as an antithrombotic target. The first mAb against (mouse) GPVI, JAQ1, was generated and used to demonstrate that GPVI requires the FcRgamma-chain for its expression and function and that this receptor is the central molecule in collagen-induced platelet activation. Blocking the major collagen binding site on GPVI with JAQ1 revealed the presence of a second activatory epitope within collagen. Additionally, the collagen receptor integrin alpha2beta1 was found to be required for activation via this second pathway but not to be essential for collagen-induced activation of normal platelets. In studies with mice expressing reduced levels of the GPVI-FcRgamma-complex, differential responses to GPVI ligands were observed. Most importantly, the striking difference between platelet responses to collagen and the GPVI specific synthetic collagen related peptide (CRP) confirmed the supportive role of other collagen receptor(s) on platelets. Irrespective of yet undefined additional receptors, studies with mice deficient in GPVI (FcRgamma-chain) or alpha2beta1 showed that GPVI, but not alpha2beta1 is essential for platelet-collagen interaction. Based on these results, the model of platelet attachment to collagen was revised establishing GPVI as the initial activating receptor which upregulates the activity of integrins, thus enabling firm attachment of platelets to the ECM. While the mAb JAQ1 had only limited inhibitory effects on collagen-induced activation in vitro, its in vivo application to mice resulted in completely abolished platelet responses to collagen and the GPVI specific agonists CRP and convulxin. This effect was found to be due to antibody-induced irreversible down-regulation of GPVI on circulating platelets for at least two weeks. Further studies revealed that GPVI depletion occurs independently of the targeted epitope on the receptor and does not require the divalent form of IgG as it was also induced by mAbs (JAQ2, JAQ3) or the respective Fab fragments directed against epitopes distinct from the major collagen binding site. The internalization of GPVI in vivo resulted in a long-term protection of the mice from lethal collagen-dependent thromboembolism whereas it had only moderate effects on the bleeding time, probably because the treatment did not affect other activation pathways. These results establish GPVI as a potential pharmacological target for the prevention of ischemic cardiovascular diseases and may open the way for a completely new generation of antithrombotics.